Article

President Obama's Health Care Reform Plan: What's in it for Nurses?

Nurses have been closely following the healthcare reform debate.

Nurses have been closely following the healthcare reform debate. We anxiously watched the February 25, 2010 summit to learn about President Obama's proposals and were relieved to hear that provisions to increase the supply of nurses and expand nursing education remained in the White House's new plan. The plan, finalized on March 5, 2010, includes funding scholarships and loan repayment programs for healthcare providers as well as grants to colleges that educate healthcare providers. It also provides incentives to recruit and retain public health workers. Some of the other key points of the plan are things that most nurses support, such as stopping insurance companies from refusing to cover people because of pre-existing conditions, regulating health insurance rate increases, close the Medicare drug coverage "donut hole," subsidize health insurance for low-income earners, increase Medicaid reimbursement, expand health savings account utilization, and provide grants for programs that address medical malpractice. President Obama's plan is available online at www.whitehouse.gov.

The American Nurses Association released a statement in support of President Obama's efforts and pledged its assistance in continuing to work with Congress to make health care reform a reality. Nurses as individuals also have been expressing how they feel about President Obama and his proposals. The website NursingLink.com has a webpage titled "Great Things About Obama" and to date, there have been over 1,300 views and 105 posts by nurses, all mostly positive.

Nurses are integral to healthcare delivery and consequently have a vested interest in President Obama's healthcare reform plan. It appears that we're finally moving toward radical change in how healthcare is delivered and paid for. It's about time.

Related Videos
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Carla Nester, MD | Credit: HCPLive
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
© 2024 MJH Life Sciences

All rights reserved.